VNS Therapy™ for Epilepsy’s Post

Did you know that there is a target range for dosing patients with VNS Therapy™? Only 6.3% of patients responded to output current and pulse width below the minimum target range. And 57.5% of responders had output current and pulse width within the target range. Reaching the target range for dosing within 3 months according to the recommended protocol results in a faster onset of response for many patients. Discover the target range here: https://bit.ly/3jKgAGC To learn more about VNS Therapy visit: https://bit.ly/3O15BlD Important safety information: https://bit.ly/3cdsPrp #vnstherapy #epilepsy #wearelivanova

Did you know that there is a target range for dosing patients with VNS Therapy™? Only 6.3% of patients responded to output current and pulse width below the minimum target range. And 57.5% of responders had output current and pulse width within the target range. Reaching the target range for dosing within 3 months according to the recommended protocol results in a faster onset of response for many patients. Discover the target range here: https://bit.ly/3jKgAGC To learn more about VNS Therapy visit: https://bit.ly/3O15BlD Important safety information: https://bit.ly/3cdsPrp #vnstherapy #epilepsy #wearelivanova

Did you know that there is a target range for dosing patients with VNS Therapy™? Only 6.3% of patients responded to output current and pulse width below the minimum target range. And 57.5% of responders had output current and pulse width within the target range. Reaching the target range for dosing within 3 months according to the recommended protocol results in a faster onset of response for many patients. Discover the target range here: https://bit.ly/3jKgAGC To learn more about VNS Therapy visit: https://bit.ly/3O15BlD Important safety information: https://bit.ly/3cdsPrp #vnstherapy #epilepsy #wearelivanova

Did you know that there is a target range for dosing patients with VNS Therapy™? Only 6.3% of patients responded to output current and pulse width below the minimum target range. And 57.5% of responders had output current and pulse width within the target range. Reaching the target range for dosing within 3 months according to the recommended protocol results in a faster onset of response for many patients. Discover the target range here: https://bit.ly/3jKgAGC To learn more about VNS Therapy visit: https://bit.ly/3O15BlD Important safety information: https://bit.ly/3cdsPrp #vnstherapy #epilepsy #wearelivanova

Next in our IV complication series: Phlebitis! Watch the video below to understand the implications of phlebitis for patients, and what happens inside the vein when there is movement on the IV line. #IVcomplications #patientcare #SafeBreakVascular #LineusMedical

Diagnosing wound infections accurately is crucial for effective treatment. Methods include wound swabs and cultures, imaging studies, clinical evaluation, patient history, and point-of-care tests. These diagnostic tools help identify the presence and severity of infections, ensuring timely and appropriate care. Learn more here: https://lnkd.in/eWd5mrQE #woundcare #infectioncontrol #medicaldiagnostics #healthcare #patientcare #woundmanagement #thewoundpros #medicaltips #clinicalevaluation #healthandwellness #nursingcare #woundhealing

MDCG 2022-9 Rev.1 changes; Introduction; Clarification on when the SSP should be made available to patients, elimination of footnote 3 Footnote 2; In line with MDCG 2019-9 rev.2 Section 1A; “Indication whether it is a device for near-patient testing and/or a companion” moved from point 1.7 to point 2.3 Section 1A, 1B and 2; ”Intended use of the device” was replaced by ”Intended purpose and other indications” in point 2.

Treating patients with aortic stenosis This new educational programme from the ESC and #ACNAP, will help you with the timely diagnosis, referral, and management of your patients with aortic stenosis. Explore the cutting-edge AortiCare resources that will improve the care pathway and patient outcomes https://bit.ly/4eMy7pt #aorticstenosis

Join us tonight for the VECCS x VIN Webinar with Marcia Fletcher! Learn about anesthetizing compromised patients, preparation, stabilization methods, and more. Check your member emails for details!

Liberty® Select with Kinexus® aims to improve efficiency, experience, and outcomes through simple, safe, and connected Peritoneal Dialysis (PD) therapy. Designed to elevate the home therapy experience for PD patients and clinicians by allowing clinicians to modify patients’ therapy program remotely. Learn more: https://bit.ly/4cQmMni Indications for Use: The Fresenius Liberty Select Cycler is indicated for acute and chronic peritoneal dialysisCaution: Federal (U.S.) law restricts this device to sale by or on the order of a physician.Note: Read the Instructions for Use for safe and proper use of this device. For a complete description of hazards, contraindications, side effects, and precautions, see full package labeling at https://bit.ly/3Lz6e7f.